British drugmaker GSK has entered into a definitive agreement to acquire US-listed lung cancer biotechnology firm Nuvalent for an aggregate... Read more
Category: Uncategorized
Roche enters $2.3 billion global collaboration with Nurix Therapeutics to co-develop BTK degrader bexobrutideg
Roche has officially announced that it has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics, Inc.. Under... Read more
Johnson & Johnson to acquire Firefly Bio for $1 billion to expand oncology pipeline
Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Firefly Bio, Inc., a biotechnology... Read more
Gilead Sciences and Lakefront Biotherapeutics combine forces to acquire Ouro Medicines in a $2.1+ billion deal
Gilead Sciences Inc. and Lakefront Biotherapeutics NV have formally finalized the acquisition of Ouro Medicines to accelerate innovative T cell... Read more
Sanofi inks five-year pact to license Owkin’s AI Scientist K Pro for next-generation biopharma agents
Sanofi has entered into a definitive multi-year licensing agreement with Owkin, an agentic AI company pioneering biological artificial superintelligence for... Read more
J&J wins lawsuit alleging talc-based baby powder caused ovarian cancer in three women
A Los Angeles jury has ruled in favor of Johnson & Johnson (J&J) in a product liability lawsuit initiated by... Read more
Incyte nears up to $2 billion acquisition of blood disorder biotech Star Therapeutics, FT reports
U.S. biotechnology company Incyte Pharma is nearing a definitive agreement valued at up to $2 billion to acquire Star Therapeutics,... Read more
Eli Lilly states next-gen obesity drug retatrutide curbs sleep apnea and eases knee pain
Drugmaker Eli Lilly has presented milestone clinical trial results to medical professionals, demonstrating that its next-generation obesity drug, retatrutide, significantly... Read more
Pfizer’s monthly obesity shot demonstrates side-effect profile comparable to Wegovy in midstage trial
Pharmaceutical giant Pfizer has presented novel clinical trial data demonstrating that a monthly dose of its experimental obesity drug exhibits... Read more









